SCHEMBL21717857

SCHEMBL21717857

Cc1cc(C)c(-c2ccc3c(c2)c2cccc4c5cc6ccccc6cc5n3c24)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.42
CYP1A2 P05177 2/20 0.42
NPY5R Q15761 2/20 0.33
IKBKB O14920 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
FTO Q9C0B1 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK14 Q16539 1/20 0.32
ESR1 P03372 3/20 0.31
ESR2 Q92731 3/20 0.31
FLT3 P36888 1/20 0.31
EGFR P00533 1/20 0.30
ERBB2 P04626 1/20 0.30
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717368 0.89 CYP2A6 (0.42) CYP2A6CYP1A2NPY5RALKBH5FTO
SCHEMBL19563792 0.89 CYP1A2 (0.43) CYP2A6CYP1A2IKBKBTDP1ALDH1A1
SCHEMBL21710652 0.89 ALKBH5 (0.42) CYP2A6CYP1A2NPY5RALKBH5FTO
SCHEMBL21718144 0.88 CYP2A6 (0.37) CYP2A6CYP1A2NPY5RALKBH5FTO
SCHEMBL26227197 0.88 CYP2A6 (0.40) CYP2A6CYP1A2IKBKBTDP1ALDH1A1
SCHEMBL21710731 0.86 ENPP3 (0.37) NPY5RALDH1A1MAPK9MAPK14CHEK1
SCHEMBL22679479 0.86 CYP1A2 (0.40) CYP2A6CYP1A2ALKBH5FTOALDH1A1
SCHEMBL21718100 0.83 ESR1 (0.44) CYP1A2NPY5RTDP1ESR1ESR2
SCHEMBL21717873 0.83 CYP2A6 (0.46) CYP2A6CYP1A2ALKBH5FTOTDP1
SCHEMBL21718165 0.81 ESR1 (0.38) CYP1A2NPY5RESR1ESR2HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 CYP2A6 3452/4885CYP1A2 1303/4885NPY5R 3775/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 CYP2A6 2475/4885CYP1A2 259/4885NPY5R 4059/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 CYP2A6 4056/4885CYP1A2 2052/4885NPY5R 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.